National Institute of Allergy and Infectious Diseases (NIAID): Rhinitis trials

The registry lists 10 Rhinitis studies with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 1 5Phase 2 6No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Subcutaneous Immunotherapy for Mouse in AdultsCompletedNCT02532179Phase 1/2Results posted
• Biomarkers of Cockroach Sublingual Immunotherapy 2CompletedNCT01380327Phase 1/2Results posted
• Development of Cockroach Immunotherapy by the Inner-City Asthma ConsortiumCompletedNCT01221285Phase 1Results posted
• Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI)CompletedNCT00829985Phase 1/2Results posted
• Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without AsthmaCompletedNCT00434421Phase 1Results posted
• Asthma Phenotypes in the Inner CityCompletedNCT01383941
• Long-Term Effects of Sublingual Grass TherapyCompletedNCT01335139Phase 2
• Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory DisordersTerminatedNCT00557895
• Treatment of Ragweed-Allergic Asthma With an Immunostimulatory DrugTerminatedNCT00318747Phase 2
• Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal AllergiesCompletedNCT00078195Phase 2